InnovaRx Innova Health Strategies

P54.6

Neonatal vaginal hemorrhage

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 12 never code together
P54code
Excludes1
  • newborn affected by (intrauterine) blood loss (P50.-)P50.-
  • pulmonary hemorrhage originating in the perinatal period (P26.-)P26.-
P50-P61block
Excludes1
  • congenital stenosis and stricture of bile ducts (Q44.3)Q44.3
  • Crigler-Najjar syndrome (E80.5)E80.5
  • Dubin-Johnson syndrome (E80.6)E80.6
  • Gilbert syndrome (E80.4)E80.4
  • hereditary hemolytic anemias (D55-D58)D55-D58
P00-P96chapter
Excludes2
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • tetanus neonatorum (A33)A33

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 3
P54.6code
Inclusion terms
  • Neonatal pseudomenses
P00-P96chapter
Notes
  • Codes from this chapter are for use on newborn records only, never on maternal records
Includes
  • conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
Index entries leading here 4
  • Bleeding — see also Hemorrhage
  • Hemorrhage, hemorrhagic (concealed) R58
  • Pseudomenses (newborn) P54.6
  • Pseudomenstruation (newborn) P54.6
Alongside this code 8 same parent — P54
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
P54
Block
P50-P61
Siblings
8

Present FY2024–FY2027.